tRF-AspGTC and Intracranial Aneurysms
Author Information
Author(s): Chao Wang, Bing Yu, Han Zhou, Huanting Li, Shifang Li, Xiaolu Li, Wentao Wang, Yugong Feng, Tao Yu
Primary Institution: The Affiliated Hospital of Qingdao University
Hypothesis
tRF-AspGTC promotes intracranial aneurysm formation by controlling TRIM29-mediated Galectin-3 ubiquitination.
Conclusion
tRF-AspGTC is a promising diagnostic biomarker and therapeutic target for intracranial aneurysms.
Supporting Evidence
- tRF-AspGTC is highly expressed in IA tissues of humans and mice.
- tRF-AspGTC promotes phenotypic switching of vascular smooth muscle cells.
- Circulating exosomal tRF-AspGTC shows strong diagnostic efficacy for IAs.
- tRF-AspGTC stabilizes galectin-3 by inhibiting its degradation.
- tRF-AspGTC activates the TLR4/MyD88/NF-κB pathway, promoting inflammation.
Takeaway
A small piece of RNA called tRF-AspGTC helps form brain aneurysms by affecting certain proteins, and it could be used to diagnose or treat these conditions.
Methodology
The study involved high-throughput sequencing, RT-qPCR, and various in vitro and in vivo experiments to assess the role of tRF-AspGTC in IA formation.
Limitations
The study had a limited sample size and ethnic variations, requiring further validation in a larger cohort.
Participant Demographics
Patients with intracranial aneurysms and healthy volunteers.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website